140 related articles for article (PubMed ID: 10846571)
1. Argyrophilic nucleolar organizer regions in colorectal malignancy: application of typing by their density.
Iwashita T; Mori H; Ito Y; Obashi A; Sugimoto K; Tei H; Hirata I; Oshiba S
Pathol Int; 1996 Mar; 46(3):204-10. PubMed ID: 10846571
[TBL] [Abstract][Full Text] [Related]
2. Argyrophilic nucleolar organizer regions in human adrenocortical neoplasms.
Kida Y; Takano Y; Okudaira M
J Cancer Res Clin Oncol; 1992; 119(1):49-54. PubMed ID: 1400566
[TBL] [Abstract][Full Text] [Related]
3. Correlation between PCNA expression and AgNOR dots in pituitary adenomas.
Klencki M; Kurnatowska I; Słowińska-Klencka D; Lewiński A; Pawlikowski M
Endocr Pathol; 2001; 12(2):163-9. PubMed ID: 11579682
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar organizer regions and PCNA expression in prostatic cancers.
Kawase N; Shiokawa A; Ota H; Saitoh T; Yoshida H; Kazama K
Pathol Int; 1994 Mar; 44(3):213-22. PubMed ID: 7517763
[TBL] [Abstract][Full Text] [Related]
6. Argyrophilic nucleolar organizer regions in proliferative lesions of the thyroid gland.
Zaczek M; Szot W; Chłap Z
Anal Quant Cytol Histol; 1996 Feb; 18(1):1-8. PubMed ID: 8851102
[TBL] [Abstract][Full Text] [Related]
7. The value of PCNA and AgNOR staining in endoscopic biopsies of gastric mucosa.
Irazusta SP; Vassallo J; Magna LA; Metze K; Trevisan M
Pathol Res Pract; 1998; 194(1):33-9. PubMed ID: 9542745
[TBL] [Abstract][Full Text] [Related]
8. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
9. Multiparameter analysis of AgNOR in thyroid lesions: comparison with PCNA expression.
Slowińska-Klencka D; Klencki M; Popowicz B; Sporny S; Lewiński A
Histol Histopathol; 2004 Jul; 19(3):785-92. PubMed ID: 15168341
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of argyrophilic nucleolar organizer regions score to differentiate suspicious malignancy in pulmonary cytology.
Chern JH; Lee YC; Yang MH; Chang SC; Perng RP
Chest; 1997 Jun; 111(6):1591-6. PubMed ID: 9187179
[TBL] [Abstract][Full Text] [Related]
11. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer region (AgNOR) in testicular tumors].
Ohyama C; Ito A; Tokuyama S; Nakazumi H; Suzuki K; Kawamura S; Sato M; Saito S; Yoshikawa K; Hoshi S
Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1543-51. PubMed ID: 7474604
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of AgNOR staining in follicular cell neoplasms of the thyroid: comparison of evaluation methods and nucleolar features.
Rüschoff J; Prasser C; Cortez T; Höhne HM; Hohenberger W; Hofstädter F
Am J Surg Pathol; 1993 Dec; 17(12):1281-8. PubMed ID: 8238736
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the biological malignancy in hepatocellular carcinoma by argyrophilic nucleolar organizer region (AgNOR) staining--morphological study of AgNOR using image analyzer].
Shiro T; Seki T; Naitoh Y; Nakagawa T; Wakabayashi M; Itoh T; Shiozaki Y; Inoue K; Okamura A
Nihon Shokakibyo Gakkai Zasshi; 1994 Mar; 91(3):267-78. PubMed ID: 7908344
[TBL] [Abstract][Full Text] [Related]
16. Progressive activity in latent prostate carcinoma defined by argyrophilic staining of the nucleolar organizer regions (AgNOR).
Konishi N; Nakaoka S; Tsuzuki T; Kitahori Y; Nishii K; Kitamura M; Ohshima M; Hiasa Y
Pathol Int; 1994 Apr; 44(4):297-302. PubMed ID: 7519105
[TBL] [Abstract][Full Text] [Related]
17. Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions in pancreatic duct cell carcinomas.
Suzuki T; Takano Y
Jpn J Cancer Res; 1993 Oct; 84(10):1072-7. PubMed ID: 7901190
[TBL] [Abstract][Full Text] [Related]
18. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
20. Utility of Argyrophilic nucleolar organizer regions (AgNOR) in differentiating malignant from benign of colorectal tumors.
Chen LT; Huang MS; Wang YL; Liu CS; Jan CM
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Nov; 11(11):615-20. PubMed ID: 7490794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
